The Latest Cardiac and Vascular News
PrecisionCHD™ is the First Integrated Epigenetic-Genetic-Based Blood Test for the Early Detection of Coronary Heart Disease CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics Holdings Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced the launch of PrecisionCHD™, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. PrecisionCHD is […]
Data across EXPLORER-HCM, MAVA-LTE and PIONEER-OLE add to the growing body of evidence from the CAMZYOS® (mavacamten) development program, reinforcing the therapeutic value and benefit to patients PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced the presentation of research supporting the company’s cardiovascular franchise at the American College of Cardiology […]
The Industry’s leading AI SaaS solution for Acute Cardiac Care bringing critical patient insights to patients’ care teams faster. CAMBRIDGE, Mass., Feb. 24, 2023 /PRNewswire/ — ConcertAI’s TeraRecon Eureka Clinical AI SaaS platform brings artificial intelligence (AI) and Deep Learning technologies to fully automate a complete echocardiography or heart ultrasound report. Us2.ai’s FDA-cleared and CE Marked echocardiogram […]
New Patent Adds to the Istaroxime Patent Estate and Provides Intellectual Property Protection Until Late 2039 WARRINGTON, Pa., Feb. 24, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for cardiovascular disorders, today announced that the United […]
GENT, Belgium–(BUSINESS WIRE)–Today, FEops announced the publication of the PREDICT-LAA study in JACC: Cardiovascular Interventions, showing that Left Atrial Appendage Closure (LAAC) procedures planned by means of FEops HEARTguide™ resulted in significant improvement of procedural efficiency and outcomes. Prof. Dr. Ole De Backer (Copenhagen, Denmark), Principal Investigator of this study, […]
ANDOVER, Mass., Feb. 23, 2023 /PRNewswire/ — Transmural Systems the leader in transcatheter electrosurgery for structural interventions announced today successful first-in-human procedure with its TELLTALE electrosurgical guidewire system. The TELLTALE Guidewire System is the first and only dedicated electrosurgical solution to simplify the BASILICA-TAVR procedure for transcatheter traversal and laceration of native […]
Expansion of the AER-901 development program to include pulmonary hypertension associated with interstitial lung disease (PH-ILD) builds on the company’s existing program in pulmonary arterial hypertension (PAH) PH-ILD shares clinical and pathophysiological features with PAH, however, there is only one currently approved therapy in PH-ILD and unmet need remains high […]
LUND, Sweden, Feb. 22, 2023 /PRNewswire/ — Syntach AB (“Syntach”) is pleased to announce that the Company’s Syntach Cardiac Support system (Syntach CS) has been selected for an oral presentation in the Best Innovation Competition to be held during the CRT 2023 annual meeting taking place at the Omni Shoreham Hotel in Washington […]
A PRIORI study to evaluate safety and performance of novel Aortix percutaneous mechanical circulatory support device to increase renal perfusion Study adds to the growing body of data for the Aortix pump, which will be featured in a late-breaking presentation at the Technology and Heart Failure Therapeutics conference in March HOUSTON, Feb. […]
ROCKVILLE, Md., Feb. 22, 2023 /PRNewswire/ — An expert consensus statement published today by the Heart Failure Society of America (HFSA) offers best practices in the management of patients on durable Mechanical Circulatory Support (MCS), focusing on pharmacological therapies administered to patients on continuous flow Left Ventricular Assist Devices (LVADs). “Over the […]
